LaNova Medicines Limited
LaNova Medicines Limited is a clinical-stage biotech company focused on developing antibody-drug conjugates (ADCs) and immuno-oncology therapies. Their R&D engine utilizes three proprietary platforms to create innovative drugs targeting significant unmet medical needs, resulting in a robust pipeline of clinical-stage assets. LaNova is committed to bringing innovative treatments to patients globally.
Buy Funded Startups lists
Funding Round: Series C1
Funding Amount: $42M
Date: 18-Oct-2024
Investors: Sino Biopharmaceuticals, Pudong Innovation Investment, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Healthcare Capital
Markets: Biotechnology, Immuno-Oncology, Antibody-Drug Conjugates (ADCs)
HQ: Shanghai, Shanghai, China
Founded: 2019
Website: https://www.lanovamedicines.com/en
LinkedIn: https://www.linkedin.com/company/lanova-medicines?trk=ppro_cprof
Leave a Comment
Comments
No comments yet.